Clinical Trial Update: Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal Impairment [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for safety study of Cenderitide in chronic stable heart failure with moderate renal impairment (Phase 1/2) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Renal Insufficiency

Drugs mentioned

• Cenderitide (CD-NP)

Snippet

Sponsor: Capricor Inc. | Conditions: Heart Failure, Renal Insufficiency | Phase 1, Phase 2 | Status: COMPLETED